Bank of Montreal’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.6K | Buy |
+13,427
| New | +$19.5K | ﹤0.01% | 3567 |
|
|
2026
Q1 | – | Sell |
-126,923
| Closed | -$237K | – | 3960 |
|
|
2025
Q4 | $237K | Buy |
126,923
+18,353
| +17% | +$35.3K | ﹤0.01% | 2741 |
|
|
2025
Q3 | $139K | Buy |
108,570
+7,695
| +8% | +$10.4K | ﹤0.01% | 2884 |
|
|
2025
Q2 | $125K | Sell |
100,875
-4,690
| -4% | -$5.42K | ﹤0.01% | 2932 |
|
|
2025
Q1 | $125K | Buy |
+105,565
| New | +$162K | ﹤0.01% | 2869 |
|
|
2024
Q4 | – | Sell |
-13,310
| Closed | -$23.3K | – | 3843 |
|
|
2024
Q3 | $23.3K | Buy |
+13,310
| New | +$21.9K | ﹤0.01% | 3555 |
|
|
2023
Q2 | – | Sell |
-13,842
| Closed | -$161K | – | 4216 |
|
|
2023
Q1 | $161K | Buy |
+13,842
| New | +$138K | ﹤0.01% | 3100 |
|
|
2022
Q1 | – | Sell |
-10,085
| Closed | -$212K | – | 4255 |
|
|
2021
Q4 | $212K | Buy |
10,085
+875
| +10% | +$21.1K | ﹤0.01% | 2939 |
|
|
2021
Q3 | $230K | Buy |
9,210
+1,354
| +17% | +$40.1K | ﹤0.01% | 3268 |
|
|
2021
Q2 | $283K | Sell |
7,856
-5,532
| -41% | -$161K | ﹤0.01% | 3081 |
|
|
2021
Q1 | $448K | Sell |
13,388
-21,488
| -62% | -$752K | ﹤0.01% | 2708 |
|
|
2020
Q4 | $1.19M | Buy |
34,876
+21,906
| +169% | +$372K | ﹤0.01% | 2117 |
|
|
2020
Q3 | $158K | Sell |
12,970
-3,856
| -23% | -$22.2K | ﹤0.01% | 2839 |
|
|
2020
Q2 | $65K | Buy |
16,826
+12,770
| +315% | +$43.5K | ﹤0.01% | 3297 |
|
|
2020
Q1 | $12K | Sell |
4,056
-17,836
| -81% | -$73K | ﹤0.01% | 3428 |
|
|
2019
Q4 | $113K | Buy |
21,892
+5,347
| +32% | +$27.2K | ﹤0.01% | 3434 |
|
|
2019
Q3 | $85K | Buy |
16,545
+662
| +4% | +$3.7K | ﹤0.01% | 3382 |
|
|
2019
Q2 | $97K | Buy |
15,883
+11,827
| +292% | +$82.9K | ﹤0.01% | 3356 |
|
|
2019
Q1 | $29K | Sell |
4,056
-1,934
| -32% | -$14K | ﹤0.01% | 3550 |
|
|
2018
Q4 | $44K | Buy |
5,990
+1,093
| +22% | +$6.92K | ﹤0.01% | 3330 |
|
|
2018
Q3 | $27K | Sell |
4,897
-24
| -0.5% | -$103 | ﹤0.01% | 3604 |
|
|
2018
Q2 | $17K | Sell |
4,921
-1,751
| -26% | -$4.86K | ﹤0.01% | 3798 |
|
|
2018
Q1 | $14K | Buy |
6,672
+2,130
| +47% | +$5.53K | ﹤0.01% | 3656 |
|
|
2017
Q4 | $12K | Sell |
4,542
-1,354
| -23% | -$4.74K | ﹤0.01% | 3725 |
|
|
2017
Q3 | $31K | Hold |
5,896
| – | – | ﹤0.01% | 3386 |
|
|
2017
Q2 | $21K | Sell |
5,896
-35,463
| -86% | -$143K | ﹤0.01% | 3527 |
|
|
2017
Q1 | $214K | Buy |
41,359
+35,463
| +601% | +$174K | ﹤0.01% | 2431 |
|
|
2016
Q4 | $45K | Hold |
5,896
| – | – | ﹤0.01% | 3147 |
|
|
2016
Q3 | $52K | Sell |
5,896
-5,000
| -46% | -$41.8K | ﹤0.01% | 3034 |
|
|
2016
Q2 | $76K | Hold |
10,896
| – | – | ﹤0.01% | 2916 |
|
|
2016
Q1 | $93K | Buy |
10,896
+3,130
| +40% | +$30.8K | ﹤0.01% | 2824 |
|
|
2015
Q4 | $102K | Sell |
7,766
-2,234
| -22% | -$20K | ﹤0.01% | 2763 |
|
|
2015
Q3 | $37K | Hold |
10,000
| – | – | ﹤0.01% | 3032 |
|
|
2015
Q2 | $58K | Hold |
10,000
| – | – | ﹤0.01% | 2965 |
|
|
2015
Q1 | $58K | Hold |
10,000
| – | – | ﹤0.01% | 2862 |
|
|
2014
Q4 | $78K | Buy |
+10,000
| New | +$64K | ﹤0.01% | 2884 |
|
|
2014
Q3 | – | Sell |
-1,290
| Closed | -$8K | – | 4304 |
|
|
2014
Q2 | $8K | Buy |
+1,290
| New | +$6.46K | ﹤0.01% | 3967 |
|
Other funds holding PACB
AIM
NAMA
Bank of Montreal's PACB Position: Q2 2026 in Review
Bank of Montreal opened a new position in Pacific Biosciences (PACB) in Q2 2026: 13,427 shares worth $22.6K. The stake represents ﹤0.01% of the portfolio and ranks #3567 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in PACB as recently as Q4 2025.
Bank of Montreal first reported a position in PACB in Q2 2014 and has held it in 37 quarters since. The position peaked at $1.19M in Q4 2020. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.
- Bank of Montreal held 13,427 shares of Pacific Biosciences worth $22.6K as of Q2 2026.
- Pacific Biosciences was a new Bank of Montreal position in Q2 2026.
- Pacific Biosciences made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3567 holding.
- Bank of Montreal first reported a position in Pacific Biosciences in Q2 2014 and has held it in 37 quarters since.
- Bank of Montreal's Pacific Biosciences position peaked at $1.19M in Q4 2020.
- 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.